A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
Pratz, Keith W., Cortes, Jorge, Roboz, Gail J., Rao, Niranjan, Arowojolu, Omotayo, Stine, Adam, Shiotsu, Yukimasa, Shudo, Aiko, Akinaga, Shiro, Small, Donald, Karp, Judith E., Levis, Mark
Published in Blood (23.04.2009)
Published in Blood (23.04.2009)
Get full text
Journal Article
Abstract 2636: Preclinical evaluation of the Hsp90 inhibitor KW-2478 in combination with bortezomib as a treatment for multiple myeloma
Ishii, Toshihiko, Nakashima, Takayuki, Seike, Toshihiro, Shudo, Aiko, Akinaga, Shiro, Soga, Shiro, Shiotsu, Yukimasa
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article